Statistics

Total Visits

Views
Prospective evaluation of the conversion rate of HER2, ER and PR between primary tumors and corresponding metastases. CONVERTHER/GEICAM 2009-03 study12

Select a period of time:

Number of views in the range

Views
Prospective evaluation of the conversion rate of HER2, ER and PR between primary tumors and corresponding metastases. CONVERTHER/GEICAM 2009-03 study5

Views

Views
December 20231
January 20241
February 20241
March 20240
April 20240
May 20242
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Ashburn2
Boardman1